×
  • Category
  • Type
  • Advanced

W8.3 Application of technological advances to clinical trials

W8.2 Systems Vaccinology

W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development?

W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?

W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New Vaccines

W7.1 Contributions of Regulatory Science to Vaccine Access

W6.3 Case Study: The Uniject Injection System

W6.2 Beyond the cold chain… Meningitis A conjugate vaccine in a controlled temperature chain: Experience from Benin

W6.1 WHO - Next-generation Vaccine Delivery Technology Meeting Summary

W5.4 Building Implementation Research Capacity for Polio Eradication

W5.3 Strengthening national capacity for evidence-based immunization policy: the case of program costing in Honduras

W5.2 Factors influencing community health volunteers in participating in health programs in Africa

W5.1 Immunization implementation research priority setting

W4.2 Prioritizing the Research Agenda for Measles and Rubella

W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella Goals

W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countries

W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategies

W2.3 Group A streptococcal vaccines: Challenges and progress

W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and Progress

W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public Health